CDMO Formex, LLC has announced that former Azo Pharma VP of Formulation Development John McCarty has joined the company as Scientific Advisor. McCarty will also serve as a member of the company’s Science Advisory Board. Formex cites McCarty’s “broad expertise in the development of all major dosage forms” and “over 17” patents.
Formex Chief Scientific Officer J. Blair West commented, “John brings a wealth of knowledge and expertise in formulation development, operations, and manufacturing for both clinical and commercial products to Formex. We are extremely pleased to work with John as our Senior Consultant and Member of our Scientific Advisory Board. John is well prepared to contribute to Formex as we continue to grow and expand in our capabilities and market presence.”
Read the Formex press release.
